The Recall Desk
ModerateFDA (Devices)·Z-2869-2016·Announced 2016-09-28

Hologic Sertera Biopsy Device Recalled for Incorrect Labeling

Hologic is recalling 570 units of the Sertera Biopsy Device due to incorrect labeling on the sterile kit.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, but the source text identifies the issue as an incorrect label without reporting any injuries, illnesses, or specific functional defects that would elevate the severity to High or Severe.

Plain-English summary

Hologic, Inc. is recalling 570 units of the Sertera Biopsy Device, Sterile, which is used primarily in ultrasound-guided breast biopsies. The recall is being conducted because of an incorrect label on the Sertera Biopsy Kit.

The affected units are identified by Lot number 15C10RA. The products were distributed nationwide. No specific dates of distribution or sales are provided in the source text.

Consumers and healthcare providers should stop using the affected Sertera Biopsy Devices and contact Hologic, Inc. for further instructions or a replacement.

The recalled product

Product
Sertera Biopsy Device, Sterile; Used primarily in ultrasound-guided breast biopsies.
Manufacturer
Hologic, Inc
Affected units
570

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot number: 15C10RA.

Distribution

Distributed nationwide across the United States.